Your account is not claimed yet. You can sign up with ORCID to claim your account.

Albrecht Betrains (A Betrains)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Acta clinica Belgica

Annals of internal medicine

Clinical rheumatology

Universitaire Ziekenhuizen Leuven

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitaire Ziekenhuizen Leuven Aug 1o 2017

Belgium

MD :: General Internal Medicine

Education History

KU Leuven Oct 1o 2019

Belgium

PHD :: Department of Microbiology, Immunology, and Transplantation - Laboratory of clinical infectious and inflammatory disease

Publications

Albrecht Betrains, Lien Moreel, Daniel Blockmans
The 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis and Takayasu arteritis: comment on the articles by Ponte et al and Grayson et al. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Albrecht Betrains, Lien Moreel, William Floyd Wright, Daniel Blockmans, Steven Vanderschueren
Negative 18F-FDG-PET imaging in fever and inflammation of unknown origin: now what? Internal and emergency medicine (2023)
Lien Moreel, Walter Coudyzer, Lennert Boeckxstaens, Albrecht Betrains, Geert Molenberghs, Steven Vanderschueren, Eveline Claus, Koen Van Laere, Daniel Blockmans
Association Between Vascular 18 F-Fluorodeoxyglucose Uptake at Diagnosis and Change in Aortic Dimensions in Giant Cell Arteritis : A Cohort Study. Annals of internal medicine (2023)
Albrecht Betrains, L Moreel, Daniel Blockmans
Comment on: 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis and Takayasu arteritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Dries Deleersnijder, P De Haes, L Peperstraete, J Buelens, Albrecht Betrains, Daniel Blockmans
Panniculitis As the First Clinical Manifestation of Myeloperoxidase-Positive Perinuclear Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Micheletti et al. Arthritis & rheumatology (Hoboken, N.J.) 73 (6) (2021)
Albrecht Betrains, Steven Vanderschueren
In reply to 'clinical biochemistry test eliminator providing cost-effectiveness with five algorithms': the Casablanca strategy. Acta clinica Belgica 76 (6) (2020)
Albrecht Betrains, Laurent Godinas, F J S H Sherida Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Veerle Compernolle, Geert Meyfroidt, Lore Vanderbeke, Valentijn Vergote, Katrien Lagrou, Peter Verhamme, Joost Wauters, Pieter Vermeersch, Timothy Devos, Piet Maes, Steven Vanderschueren
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies. British journal of haematology 192 (6) (2020)
K Wellekens, Albrecht Betrains, Paul De Munter, W Peetermans
Dengue: current state one year before WHO 2010-2020 goals. Acta clinica Belgica (2020)
Albrecht Betrains, Wouter Rosseels, Elke Van Mieghem, Steven Vanderschueren, Jochen Nijs
Clinical characteristics, treatment, and outcome of pancreatitis, panniculitis, and polyarthritis syndrome: a case-based review. Clinical rheumatology 40 (4) (2020)

Albrecht Betrains.css-eqlu8i{font-size:small;padding-left:4px;} (A Betrains)

Publication Activity (10 Years)

Top Topics

Top Venues

Albrecht Betrains (A Betrains)